NCT07432009

Brief Summary

This multicenter, prospective, non-interventional observational study (ORTOPODCZ) investigates the association between preoperative cognitive impairment and postoperative delirium (POD) in older adults undergoing elective total hip arthroplasty in the Czech Republic. Postoperative delirium is a frequent and serious neurocognitive complication in senior surgical patients and is associated with increased morbidity, mortality, prolonged hospitalization, and impaired functional and cognitive outcomes. Despite international recommendations, routine preoperative cognitive screening remains insufficiently implemented. The study evaluates the predictive value of the ALBA test, a brief cognitive screening tool, performed during the pre-anesthetic assessment. Postoperative delirium will be assessed using the validated CAM-ICU instrument for up to 72 hours after surgery. Secondary objectives include assessing the relationship between POD and frailty, polypharmacy, comorbidities, type of anesthesia, intraoperative hemodynamics, blood loss, vasoactive support, and postoperative complications. Approximately 300-400 participants aged ≥65 years will be enrolled across seven centers. No additional procedures, biological sampling, or deviations from standard clinical care are required. Data will be collected in REDCap and analyzed according to a predefined statistical analysis plan. The study aims to provide robust evidence supporting the integration of cognitive screening into routine preoperative evaluation and to describe feasibility and implementation requirements for the ALBA test in clinical practice.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
48mo left

Started Apr 2026

Longer than P75 for all trials

Geographic Reach
1 country

7 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Apr 2026Mar 2030

First Submitted

Initial submission to the registry

February 18, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 25, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2029

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2030

Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

3.8 years

First QC Date

February 18, 2026

Last Update Submit

February 24, 2026

Conditions

Keywords

ALBA testCAM-ICUCognitive ScreeningGeriatric PatientsPerioperative Neurocognitive DisordersPolypharmacyClinical Frailty ScaleTotal Hip ReplacementObservational StudyProspective Cohort

Outcome Measures

Primary Outcomes (1)

  • Incidence of postoperative delirium (POD)

    POD will be assessed using the CAM-ICU tool. Delirium is considered present if at least one CAM-ICU assessment is positive within the first 72 hours after surgery. The outcome will be expressed as the percentage of patients with POD.

    0-72 hours after surgery

Secondary Outcomes (9)

  • Frailty score measured using the Clinical Frailty Scale (CFS)

    Preoperative assessment

  • Number of comorbidities present preoperatively

    Preoperative assessment

  • Presence of polypharmacy (>5 regular medications)

    Preoperative medication list

  • Presence of preoperative anemia

    Preoperative assessment

  • Type of anesthesia used (general vs. regional)

    0-72 hours after surgery

  • +4 more secondary outcomes

Study Arms (1)

Cohort of older adults undergoing elective total hip arthroplasty

Prospective cohort of patients aged 65 years and older undergoing elective total hip arthroplasty in standard clinical care. All participants receive routine perioperative management. No interventions are assigned as part of the study.

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Prospective cohort of patients aged 65 years and older undergoing elective total hip arthroplasty in seven hospitals in the Czech Republic. All participants receive standard perioperative care. No interventions are assigned as part of the study; only observational data are collected.

You may qualify if:

  • Age ≥ 65 years
  • Elective total hip arthroplasty in general or regional anesthesia
  • ASA physical status I-III
  • Ability to understand and cooperate during testing; no severe sensory impairment (compensatory aids allowed)
  • Expected postoperative hospitalization in ICU, PACU, or standard ward

You may not qualify if:

  • Glasgow Coma Scale ≤ 14
  • Limited legal capacity
  • Active psychiatric disorder (e.g., psychotic disorder, bipolar disorder)
  • Active oncological disease
  • Chronic use of strong opioids
  • Premedication with anxiolytics or antipsychotics during preanesthetic evaluation
  • Acute reoperation within 3 months of primary surgery
  • Refusal to participate or withdrawal of consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

University Hospital Brno - Bohunice

Brno, 62500, Czechia

Location

University Hospital Olomouc - Department of Anaesthesiology, Resuscitation and Intensive Care

Olomouc, 77900, Czechia

Location

University Hospital Ostrava - Department of Anaesthesiology, Resuscitation and Intensive Care

Ostrava, Czechia

Location

University Hospital Královské Vinohrady

Prague, 10034, Czechia

Location

University Hospital Motol

Prague, 15006, Czechia

Location

Vsetín Hospital

Vsetín, Czechia

Location

Tomas Bata Regional Hospital

Zlín, 6275, Czechia

Location

MeSH Terms

Conditions

FrailtyCognitive DysfunctionEmergence Delirium

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsCognition DisordersNeurocognitive DisordersMental DisordersDeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsSigns and Symptoms

Central Study Contacts

Klára Nekvindová, M.D, Ph.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Department of Anesthesiology, Resuscitation and Intensive Car

Study Record Dates

First Submitted

February 18, 2026

First Posted

February 25, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

December 31, 2029

Study Completion (Estimated)

March 31, 2030

Last Updated

February 25, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared because this is a multicenter observational study conducted under strict GDPR requirements. The study does not include a data-sharing framework or governance structure that would allow external access to pseudonymized datasets. Data will be used exclusively for the purposes defined in the study protocol and handled according to institutional and national data protection regulations.

Locations